In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation

K. Oktay, Erkan Buyuk, K. A. Rodriguez-Wallberg, G. Sahin

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

This study tested in-vitro maturation (IVM) as a complementary strategy to improve the mature oocyte yield of breast cancer patients undergoing ovarian stimulation for fertility preservation. Secondary analysis of prospectively collected data is performed for 32 breast cancer patients undergoing oocyte or embryo cryopreservation before chemotherapy. Total number of oocytes and/or embryos cryopreserved following IVM is compared with the total number cryopreserved before IVM. Overall, 464 oocytes were retrieved, of which 274 were mature. Following IVM, the number of total mature oocytes increased to 399 (45% increase in mature oocyte yield, P < 0.0001). Fertilization rate after IVM was statistically significantly higher than the fertilization of already mature oocytes at retrieval (86% versus 73%, respectively, P < 0.05). The total number of oocytes and embryos frozen before IVM was 207 (45% of all oocytes retrieved). This number increased to 320 (69% of all oocytes retrieved) following IVM (P < 0.0001 ). IVM is a useful strategy to improve the mature oocyte yield of fertility preservation cycles. Immature oocytes retrieved during oocyte/embryo cryopreservation cycles should not be discarded to improve the future potential of fertility.

Original languageEnglish (US)
Pages (from-to)634-638
Number of pages5
JournalReproductive BioMedicine Online
Volume20
Issue number5
DOIs
StatePublished - May 2010

Fingerprint

Fertility Preservation
In Vitro Oocyte Maturation Techniques
Ovulation Induction
Cryopreservation
Oocytes
Embryonic Structures
Breast Neoplasms
Fertilization
Oocyte Retrieval
In Vitro Techniques
Fertility

Keywords

  • Cryopreservation
  • Embryo
  • Fertility preservation
  • In-vitro maturation
  • Oocyte

ASJC Scopus subject areas

  • Reproductive Medicine
  • Developmental Biology

Cite this

In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. / Oktay, K.; Buyuk, Erkan; Rodriguez-Wallberg, K. A.; Sahin, G.

In: Reproductive BioMedicine Online, Vol. 20, No. 5, 05.2010, p. 634-638.

Research output: Contribution to journalArticle

@article{a1cb5be45ed6436e9f8e68f78945ca67,
title = "In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation",
abstract = "This study tested in-vitro maturation (IVM) as a complementary strategy to improve the mature oocyte yield of breast cancer patients undergoing ovarian stimulation for fertility preservation. Secondary analysis of prospectively collected data is performed for 32 breast cancer patients undergoing oocyte or embryo cryopreservation before chemotherapy. Total number of oocytes and/or embryos cryopreserved following IVM is compared with the total number cryopreserved before IVM. Overall, 464 oocytes were retrieved, of which 274 were mature. Following IVM, the number of total mature oocytes increased to 399 (45{\%} increase in mature oocyte yield, P < 0.0001). Fertilization rate after IVM was statistically significantly higher than the fertilization of already mature oocytes at retrieval (86{\%} versus 73{\%}, respectively, P < 0.05). The total number of oocytes and embryos frozen before IVM was 207 (45{\%} of all oocytes retrieved). This number increased to 320 (69{\%} of all oocytes retrieved) following IVM (P < 0.0001 ). IVM is a useful strategy to improve the mature oocyte yield of fertility preservation cycles. Immature oocytes retrieved during oocyte/embryo cryopreservation cycles should not be discarded to improve the future potential of fertility.",
keywords = "Cryopreservation, Embryo, Fertility preservation, In-vitro maturation, Oocyte",
author = "K. Oktay and Erkan Buyuk and Rodriguez-Wallberg, {K. A.} and G. Sahin",
year = "2010",
month = "5",
doi = "10.1016/j.rbmo.2010.01.012",
language = "English (US)",
volume = "20",
pages = "634--638",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation

AU - Oktay, K.

AU - Buyuk, Erkan

AU - Rodriguez-Wallberg, K. A.

AU - Sahin, G.

PY - 2010/5

Y1 - 2010/5

N2 - This study tested in-vitro maturation (IVM) as a complementary strategy to improve the mature oocyte yield of breast cancer patients undergoing ovarian stimulation for fertility preservation. Secondary analysis of prospectively collected data is performed for 32 breast cancer patients undergoing oocyte or embryo cryopreservation before chemotherapy. Total number of oocytes and/or embryos cryopreserved following IVM is compared with the total number cryopreserved before IVM. Overall, 464 oocytes were retrieved, of which 274 were mature. Following IVM, the number of total mature oocytes increased to 399 (45% increase in mature oocyte yield, P < 0.0001). Fertilization rate after IVM was statistically significantly higher than the fertilization of already mature oocytes at retrieval (86% versus 73%, respectively, P < 0.05). The total number of oocytes and embryos frozen before IVM was 207 (45% of all oocytes retrieved). This number increased to 320 (69% of all oocytes retrieved) following IVM (P < 0.0001 ). IVM is a useful strategy to improve the mature oocyte yield of fertility preservation cycles. Immature oocytes retrieved during oocyte/embryo cryopreservation cycles should not be discarded to improve the future potential of fertility.

AB - This study tested in-vitro maturation (IVM) as a complementary strategy to improve the mature oocyte yield of breast cancer patients undergoing ovarian stimulation for fertility preservation. Secondary analysis of prospectively collected data is performed for 32 breast cancer patients undergoing oocyte or embryo cryopreservation before chemotherapy. Total number of oocytes and/or embryos cryopreserved following IVM is compared with the total number cryopreserved before IVM. Overall, 464 oocytes were retrieved, of which 274 were mature. Following IVM, the number of total mature oocytes increased to 399 (45% increase in mature oocyte yield, P < 0.0001). Fertilization rate after IVM was statistically significantly higher than the fertilization of already mature oocytes at retrieval (86% versus 73%, respectively, P < 0.05). The total number of oocytes and embryos frozen before IVM was 207 (45% of all oocytes retrieved). This number increased to 320 (69% of all oocytes retrieved) following IVM (P < 0.0001 ). IVM is a useful strategy to improve the mature oocyte yield of fertility preservation cycles. Immature oocytes retrieved during oocyte/embryo cryopreservation cycles should not be discarded to improve the future potential of fertility.

KW - Cryopreservation

KW - Embryo

KW - Fertility preservation

KW - In-vitro maturation

KW - Oocyte

UR - http://www.scopus.com/inward/record.url?scp=77952876421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952876421&partnerID=8YFLogxK

U2 - 10.1016/j.rbmo.2010.01.012

DO - 10.1016/j.rbmo.2010.01.012

M3 - Article

C2 - 20219430

AN - SCOPUS:77952876421

VL - 20

SP - 634

EP - 638

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 5

ER -